IP Library Granted Patent US 8,808,704
Granted Patent B2
US 8,808,704 · App. 12/162,566 · Granted Aug 19, 2014

Non-coiled protective regions of pneumococcal surface proteins PspA and PspC

Inventors: Susan K. Hollingshead (Birmingham, AL); David E. Briles (Birmingham, AL)
Assignee: The UAB Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,808,704
App. No.
12/162,566
Granted
Aug 19, 2014
Kind
B2
Abstract

The embodiments described herein provide for immunogenic portions of Streptococcus pneumoniae surface protein A and surface protein C lacking alpha helical structure.

Claims (5)

1. An immunogenic composition comprising a pharmaceutically acceptable carrier or an adjuvant and at least one purified, immunogenic, recombinant polypeptide of Streptococcus pneumoniae surface protein A (PspA) consisting of SEQ. ID, NO:1, SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:45, amino acid residues 159-267 of SEQ ID NO:20, or amino acid residues 159-263 of SEQ ID NO:18; wherein said polypeptide lacks an alpha-helical region of the full length PspA; and wherein said polypeptide is immunogenic against S. pneumoniae.

2. A vaccine comprising the immunogenic composition of claim 1 .

3. The vaccine of claim 2 , in which said composition comprises at least one polypeptide consisting of SEQ. ID, NO: 1, SEQ ID NO: 2, SEQ ID NO: 4 or amino acid residues 159-263 of SEQ ID NO: 18.

4. An immunogenic composition comprising a pharmaceutically acceptable carrier or an adjuvant and at least one purified, recombinant protein consisting of amino acid residues 159-263 of SEQ ID NO: 18; wherein the polypeptide lacks an alpha-helical region of the full length PspA; and wherein the composition is immunogenic against S. pneumoniae.

5. A vaccine comprising the immunogenic composition of claim 4 .

Assignments (2)
CONFIRMATORY LICENSE Recorded Nov 8, 2021
From: UNIVERSITY OF ALABAMA AT BIRMINGHAM
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 058831/0360 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2008
From: HOLLINGSHEAD, SUSAN K.; BRILES, DAVID E.
To: THE UAB RESEARCH FOUNDATION
Reel/Frame 021894/0297 →
Continuity (3)
Provisional Application 60764731 · Feb 2, 2006
Provisional Application 60851510 · Oct 13, 2006
Related Publication 20090170162A1 · Jul 2, 2009